Literature DB >> 6995478

Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor.

G L King, C R Kahn, M M Rechler, S P Nissley.   

Abstract

Insulin and such insulinlike growth factors as multiplication stimulating activity (MSA) are related polypeptides that have common biological activities. Both insulin and MSA produce acute metabolic responses (stimulation of glucose oxidation in isolated fat cells) as well as growth effects (stimulation of [(3)H]thymidine incorporation into DNA in cultured fibroblasts). In addition, most cells have separate receptors for insulin and insulinlike growth factors, and both peptides have weaker affinity for each other's specific receptors than for their own. To determine, therefore, whether these effects are mediated by receptors for insulin, insulinlike growth factors, or both, we have selectively blocked insulin receptors with a specific antagonist, namely Fab fragments derived from naturally occurring antibodies to the insulin receptor. In rat adipocytes, 10 mug/ml of antireceptor Fab inhibited insulin binding by 90%, whereas it inhibited MSA binding <5%. The anti-insulin receptor Fab is without intrinsic biological activity, but acts as a competitive inhibitor of insulin receptors. Blockade of insulin receptors with Fab fragments produced a 30-fold rightward shift in the dose response for stimulation of glucose oxidation by both insulin and MSA. The dose-response curves for stimulation of oxidation by vitamin K(5) and spermine, agents that stimulate glucose oxidation through noninsulin receptor pathways, were not affected by the blockade of insulin receptors with Fab antibody fragments. These data suggest that this acute metabolic effect of both insulin and MSA is mediated via the insulin receptor. In cultured human fibroblasts, 10 mug/ml of Fab inhibited insulin binding by 90% and MSA binding by 15%. In fibroblasts, however, blockade of the insulin receptor did not alter the dose response for stimulation of thymidine incorporation into DNA by either insulin or MSA. Furthermore, intact antireceptor antibody immunoglobulin (Ig)G, which produces multiple other insulinlike effects, and Fab fragments of antireceptor antibody did not stimulate thymidine incorporation. These data demonstrate directly that the insulin receptor mediates the metabolic effects of insulin and MSA, whereas the growth-promoting action of both peptides is mediated by the MSA receptor or other growth factors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995478      PMCID: PMC371514          DOI: 10.1172/JCI109826

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Insulin and non-suppressible insulin-like activity (NSILA-s): evidence for separate plasma membrane receptor sites.

Authors:  K Megyesi; C R Kahn; J Roth; E R Froesch; R E Humbel; J Zapf; D M Neville
Journal:  Biochem Biophys Res Commun       Date:  1974-03-15       Impact factor: 3.575

2.  DNA synthesis in human fibroblasts: stimulation by insulin and by nonsuppressible insulin-like activity (NSILA-S).

Authors:  M M Rechler; J M Podskalny; I D Goldfine; C A Wells
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

3.  Insulin-like activity of concanavalin A and wheat germ agglutinin--direct interactions with insulin receptors.

Authors:  P Cuatrecasas; G P Tell
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

4.  Binding and degradation of 125I-labelled insulin by isolated rat fat cells.

Authors:  S Gammeltoft; J Gliemann
Journal:  Biochim Biophys Acta       Date:  1973-08-17

5.  Protein A from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins.

Authors:  H Hjelm; K Hjelm; J Sjöquist
Journal:  FEBS Lett       Date:  1972-11-15       Impact factor: 4.124

6.  Stimulation of glucose metabolism by lectins in isolated white fat cells.

Authors:  M P Czech; W S Lynn
Journal:  Biochim Biophys Acta       Date:  1973-02-28

7.  Human somatomedin, the growth hormone dependent sulfation factor, is antilipolytic.

Authors:  L E Underwood; R L Hintz; S J Voina; J J Van Wyk
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

8.  Insulin interactions with liver plasma membranes. Independence of binding of the hormone and its degradation.

Authors:  P Freychet; R Kahn; J Roth; D M Neville
Journal:  J Biol Chem       Date:  1972-06-25       Impact factor: 5.157

9.  Nonsuppressible insulin-like activity of human serum. IV. Effects of purified nonsuppressible insulin-like activity and of insulin on protein synthesis of adipose tissue from [14C]glucose, [14C]pyruvate and [14C]glycine.

Authors:  U Buxtorf
Journal:  Biochim Biophys Acta       Date:  1969-05-06

10.  Competitive binding of somatomedin to the insulin receptors of adipocytes, chondrocytes, and liver membranes.

Authors:  R L Hintz; D R Clemmons; L E Underwood; J J Van Wyk
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

View more
  69 in total

Review 1.  Pancreatic beta-cell growth and diabetes mellitus.

Authors:  I Swenne
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

2.  Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cells.

Authors:  Min Sun Kim; Dae-Yeol Lee
Journal:  Mol Cell Biochem       Date:  2015-02-07       Impact factor: 3.396

3.  Identification of persistent defects in insulin receptor structure and function capillary endothelial cells from diabetic rats.

Authors:  C F Kwok; B J Goldstein; D Muller-Wieland; T S Lee; C R Kahn; G L King
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

4.  Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro.

Authors:  V F Tapson; M Boni-Schnetzler; P F Pilch; D M Center; J S Berman
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

5.  Insulin and insulin-like-growth-factor-I (IGF-I) receptors in Xenopus laevis oocytes. Comparison with insulin receptors from liver and muscle.

Authors:  P Hainaut; A Kowalski; S Giorgetti; V Baron; E Van Obberghen
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

6.  The effect of acute and chronic insulin administration on insulin-like growth factor-I expression in the pituitary-intact and hypophysectomised rat.

Authors:  E A Salamon; J Luo; L J Murphy
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

7.  Sharing of biological effect and receptors between guinea pig insulin and platelet-derived growth factor.

Authors:  G L King; C R Kahn; C H Heldin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

8.  The effect of insulin-like growth factor II on glucose uptake and metabolism in rat skeletal muscle in vitro.

Authors:  S J Bevan; M Parry-Billings; E Opara; C T Liu; D B Dunger; E A Newsholme
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

9.  Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone.

Authors:  A Debant; E Clauser; G Ponzio; C Filloux; C Auzan; J O Contreres; B Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

Review 10.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.